The significant rise of serum sialic acid (an indicator of the acute-phase reaction), α-1 acid glycoprotein, IL-6 among three groups were also observed, as follows: the lowest content in nondiabetic patients, middle content in a T2DM group without metabolic syndrome, and the highest content in patients with metabolic syndrome (85). The gene discussed is IL6; the disease is metabolic syndrome.